Chemically modified oligonucleotides

Details for Australian Patent Application No. 2005272816 (hide)

Owner Alnylam Pharmaceuticals, Inc.

Inventors Kesavan, Venkitasamy; Manoharan, Muthiah; Rajeev, Kallanthottathil G.

Agent Griffith Hack

Pub. Number AU-B-2005272816

PCT Pub. Number WO2006/020768

Priority 60/600,703 10.08.04 US

Filing date 10 August 2005

Wipo publication date 23 February 2006

Acceptance publication date 11 August 2011

International Classifications

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

A61K 31/70 (2006.01) - Carbohydrates

Event Publications

22 March 2007 PCT application entered the National Phase

  PCT publication WO2006/020768 Priority application(s): WO2006/020768

11 August 2011 Application Accepted

  Published as AU-B-2005272816

8 December 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005272821-Methods for preparing freeze-dried platelets, compositions comprising freeze-dried platelets, and methods of use

2005272815-Thiazole based inhibitors of ATPutilizing enzymes